• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析前变量对血液和尿液样本中游离DNA分析的影响。

The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples.

作者信息

Peng Hongwei, Pan Ming, Zhou Zongning, Chen Congbo, Xing Xing, Cheng Shaoping, Zhang Shanshan, Zheng Hang, Qian Kaiyu

机构信息

Department of Biological Repositories, Human Genetic Resources Preservation Center of Hubei Province, Hubei Key Laboratory of Urological Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China.

Taihe Skills Training Center, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.

出版信息

Front Cell Dev Biol. 2024 May 9;12:1385041. doi: 10.3389/fcell.2024.1385041. eCollection 2024.

DOI:10.3389/fcell.2024.1385041
PMID:38784382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11111958/
Abstract

Cell-free DNA (cfDNA), a burgeoning class of molecular biomarkers, has been extensively studied across a variety of biomedical fields. As a key component of liquid biopsy, cfDNA testing is gaining prominence in disease detection and management due to the convenience of sample collection and the abundant wealth of genetic information it provides. However, the broader clinical application of cfDNA is currently impeded by a lack of standardization in the preanalytical procedures for cfDNA analysis. A number of fundamental challenges, including the selection of appropriate preanalytical procedures, prevention of short cfDNA fragment loss, and the validation of various cfDNA measurement methods, remain unaddressed. These existing hurdles lead to difficulties in comparing results and ensuring repeatability, thereby undermining the reliability of cfDNA analysis in clinical settings. This review discusses the crucial preanalytical factors that influence cfDNA analysis outcomes, including sample collection, transportation, temporary storage, processing, extraction, quality control, and long-term storage. The review provides clarification on achievable consensus and offers an analysis of the current issues with the goal of standardizing preanalytical procedures for cfDNA analysis.

摘要

游离DNA(cfDNA)是一类新兴的分子生物标志物,已在各种生物医学领域得到广泛研究。作为液体活检的关键组成部分,cfDNA检测因样本采集方便且能提供丰富的遗传信息,在疾病检测和管理中日益受到重视。然而,目前cfDNA更广泛的临床应用受到cfDNA分析前处理程序缺乏标准化的阻碍。一些基本挑战,包括选择合适的分析前程序、防止短cfDNA片段丢失以及验证各种cfDNA测量方法,仍未得到解决。这些现存的障碍导致结果比较困难且难以确保可重复性,从而削弱了cfDNA分析在临床环境中的可靠性。本综述讨论了影响cfDNA分析结果的关键分析前因素,包括样本采集、运输、临时储存、处理、提取、质量控制和长期储存。该综述阐明了可达成的共识,并对当前问题进行了分析,目的是使cfDNA分析的分析前程序标准化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b1/11111958/08ac612299f4/fcell-12-1385041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b1/11111958/2ca4dcd818d0/fcell-12-1385041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b1/11111958/08ac612299f4/fcell-12-1385041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b1/11111958/2ca4dcd818d0/fcell-12-1385041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56b1/11111958/08ac612299f4/fcell-12-1385041-g002.jpg

相似文献

1
The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples.分析前变量对血液和尿液样本中游离DNA分析的影响。
Front Cell Dev Biol. 2024 May 9;12:1385041. doi: 10.3389/fcell.2024.1385041. eCollection 2024.
2
Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.分析前和分析方法对游离DNA诊断的影响。
Front Cell Dev Biol. 2021 Sep 6;9:686149. doi: 10.3389/fcell.2021.686149. eCollection 2021.
3
Preanalytical variables that affect the outcome of cell-free DNA measurements.影响游离 DNA 测量结果的分析前变量。
Crit Rev Clin Lab Sci. 2020 Nov;57(7):484-507. doi: 10.1080/10408363.2020.1750558. Epub 2020 May 12.
4
Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.优化 cfDNA 处理的预分析变量并检测存档血浆样本中的 ctDNA。
Biomed Res Int. 2021 Jul 8;2021:5585148. doi: 10.1155/2021/5585148. eCollection 2021.
5
Developing Quality Programs for Cell-Free DNA (cfDNA) Extraction from Peripheral Blood.开发外周血游离 DNA(cfDNA)提取的质量计划。
J Appl Lab Med. 2020 Jul 1;5(4):788-797. doi: 10.1093/jalm/jfaa050.
6
Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.采用液滴数字 PCR 进行游离 DNA 分析的前分析血液样本工作流程,用于未来的分子癌症诊断。
Cancer Med. 2017 Oct;6(10):2297-2307. doi: 10.1002/cam4.1184. Epub 2017 Sep 21.
7
Adjustments to the preanalytical phase of quantitative cell-free DNA analysis.对定量游离DNA分析的分析前阶段的调整。
Data Brief. 2015 Dec 17;6:326-9. doi: 10.1016/j.dib.2015.12.009. eCollection 2016 Mar.
8
A Synthetic DNA Construct to Evaluate the Recovery Efficiency of Cell-Free DNA Extraction and Bisulfite Modification.用于评估无细胞 DNA 提取和亚硫酸氢盐修饰回收率的合成 DNA 构建体。
Clin Chem. 2021 Sep 1;67(9):1201-1209. doi: 10.1093/clinchem/hvab095.
9
Cell-free DNA: Preanalytical variables.无细胞 DNA:分析前变量。
Clin Chim Acta. 2015 Oct 23;450:243-53. doi: 10.1016/j.cca.2015.08.028. Epub 2015 Sep 2.
10
Investigation of Preanalytical Variables Impacting Pathogen Cell-Free DNA in Blood and Urine.探究影响血液和尿液中病原体无细胞 DNA 的分析前变量。
J Clin Microbiol. 2019 Oct 23;57(11). doi: 10.1128/JCM.00782-19. Print 2019 Nov.

引用本文的文献

1
Evaluation of the Effectiveness and Accuracy of Non-Invasive Preimplantation Genetic Testing (niPGT) Compared to Invasive Embryo Biopsy.与侵入性胚胎活检相比,非侵入性胚胎植入前基因检测(niPGT)的有效性和准确性评估。
Biomedicines. 2025 Aug 18;13(8):2010. doi: 10.3390/biomedicines13082010.
2
Triple-mode point-of-care diagnostics for high-risk human papillomavirus in urine.尿液中高危型人乳头瘤病毒的三联即时诊断
Biosens Bioelectron X. 2025 Oct;26. doi: 10.1016/j.biosx.2025.100658. Epub 2025 Jul 7.
3
Circulating-free DNA: A promising tool for early detection of myocardial infarction.

本文引用的文献

1
Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality.游离 DNA 提取:效率、数量和质量评估。
J Mol Diagn. 2024 Apr;26(4):310-319. doi: 10.1016/j.jmoldx.2024.01.008. Epub 2024 Feb 2.
2
The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine.临床常规操作中稳定、提取和分析尿液游离DNA(ucfDNA)面临的挑战。
Diagnostics (Basel). 2023 Dec 14;13(24):3670. doi: 10.3390/diagnostics13243670.
3
Cell-free DNA extraction from urine of lung cancer patients and healthy individuals: Evaluation of a simple method using sample volume up-scaling.
循环游离DNA:心肌梗死早期检测的一种有前景的工具。
Int J Cardiol Cardiovasc Risk Prev. 2025 Aug 5;27:200484. doi: 10.1016/j.ijcrp.2025.200484. eCollection 2025 Dec.
4
Design, Development, and Clinical Validation of a Novel Kit for Cell-Free DNA Extraction.一种新型无细胞DNA提取试剂盒的设计、开发及临床验证
Diagnostics (Basel). 2025 Jul 29;15(15):1897. doi: 10.3390/diagnostics15151897.
5
Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectives.基于循环肿瘤DNA的液体活检敏感性的提高:当前方法与未来展望
Explor Target Antitumor Ther. 2025 Aug 8;6:1002333. doi: 10.37349/etat.2025.1002333. eCollection 2025.
6
Impact of Long-Term Plasma Storage on Cell-Free DNA Epigenetic Biomarker Studies.长期血浆储存对游离DNA表观遗传生物标志物研究的影响。
Biomolecules. 2025 Jun 25;15(7):927. doi: 10.3390/biom15070927.
7
Relative mtDNA copy number in embryo spent culture medium is not a reliable biomarker of human embryo aneuploidy.胚胎培养液中的相对线粒体DNA拷贝数并非人类胚胎非整倍体的可靠生物标志物。
Reprod Fertil. 2025 Apr 29;6(2). doi: 10.1530/RAF-25-0001. Print 2025 Apr 1.
8
Application of Digital Polymerase Chain Reaction (dPCR) in Non-Invasive Prenatal Testing (NIPT).数字聚合酶链反应(dPCR)在无创产前检测(NIPT)中的应用。
Biomolecules. 2025 Mar 1;15(3):360. doi: 10.3390/biom15030360.
9
The Potential of cfDNA as Biomarker: Opportunities and Challenges for Neurodegenerative Diseases.循环游离DNA作为生物标志物的潜力:神经退行性疾病面临的机遇与挑战
J Mol Neurosci. 2025 Mar 13;75(1):34. doi: 10.1007/s12031-025-02317-8.
10
Pre-analytical pitfalls: How blood collection tubes influence exercise-induced cell-free DNA concentrations.分析前的陷阱:采血管如何影响运动诱导的游离DNA浓度。
Exp Physiol. 2025 Mar 3. doi: 10.1113/EP092284.
从肺癌患者和健康个体的尿液中提取无细胞 DNA:使用样本体积放大评估一种简单方法。
J Clin Lab Anal. 2023 Nov;37(21-22):e24984. doi: 10.1002/jcla.24984. Epub 2023 Nov 22.
4
Impact of Cell-Debris and Room-Temperature Storage on Urine Circulating Tumor DNA from Hepatocellular Carcinoma.细胞碎片和室温储存对肝癌患者尿液循环肿瘤 DNA 的影响。
J Mol Diagn. 2023 Dec;25(12):913-920. doi: 10.1016/j.jmoldx.2023.08.006. Epub 2023 Oct 9.
5
Engineered bacteria detect tumor DNA.工程菌检测肿瘤 DNA。
Science. 2023 Aug 11;381(6658):682-686. doi: 10.1126/science.adf3974. Epub 2023 Aug 10.
6
UAS™-A Urine Preservative for Oncology Applications.UAS™-A用于肿瘤学应用的尿液防腐剂。
Cancers (Basel). 2023 Jun 8;15(12):3119. doi: 10.3390/cancers15123119.
7
Metasurface Biosensors Enabling Single-Molecule Sensing of Cell-Free DNA.基于超表面的生物传感器可实现游离 DNA 的单分子检测。
Nano Lett. 2023 Jun 28;23(12):5755-5761. doi: 10.1021/acs.nanolett.3c01527. Epub 2023 Jun 14.
8
Size and Concentration of Cell-Free DNA Measured Directly from Blood Plasma, without Prior DNA Extraction.直接从血浆中测量无预先 DNA 提取的游离 DNA 的大小和浓度。
Anal Chem. 2023 Jun 20;95(24):9263-9270. doi: 10.1021/acs.analchem.3c00998. Epub 2023 Jun 6.
9
The origin and possible mechanism of embryonic cell-free DNA release in spent embryo culture media: a review.胚胎培养液中游离 DNA 释放的来源和可能机制:综述。
J Assist Reprod Genet. 2023 Jun;40(6):1231-1242. doi: 10.1007/s10815-023-02813-z. Epub 2023 May 2.
10
DNA in fresh urine supernatant is not affected by additional centrifugation and is protected against deoxyribonuclease.新鲜尿液上清液中的DNA不受额外离心的影响,并且能抵御脱氧核糖核酸酶的作用。
Mol Cell Probes. 2023 Apr;68:101900. doi: 10.1016/j.mcp.2023.101900. Epub 2023 Feb 18.